Omada Health director granted 915 RSUs

Q: What insider transaction did Omada Health (OMDA) report in this Form 4?

Omada Health reported that director Jonathan D. Root was granted 915 restricted stock units (RSUs) of Common Stock on January 5, 2026, at a price of $0 per share.

Q: How many Omada Health (OMDA) shares does Jonathan D. Root own after this RSU grant?

After the reported RSU grant, Jonathan D. Root beneficially owns 179,293 shares of Omada Health Common Stock in direct ownership.

Q: What do the 915 RSUs granted to Omada Health (OMDA) director Jonathan D. Root represent?

Each of the 915 RSUs represents the right to receive one share of Omada Health Common Stock, with settlement occurring on a date selected by Mr. Root under the Non-Employee Director Compensation Program or as otherwise provided by that program.

Q: Why did Omada Health (OMDA) grant RSUs instead of cash to Jonathan D. Root?

The filing states the RSUs were granted in lieu of retainer fees under Omada Health’s Non-Employee Director Compensation Program, effectively replacing a portion of cash director compensation with equity-based awards.

Q: Does Jonathan D. Root hold the Omada Health (OMDA) shares directly or indirectly?

The Form 4 reports direct ownership (D) for the 179,293 shares of Omada Health Common Stock beneficially owned following the RSU grant.

Omada Health, Inc. director Jonathan D. Root received 915 restricted stock units (RSUs) of Common Stock on January 5, 2026.

Accepted by SEC EDGAR 01/07/2026 - 05:37 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. director Jonathan D. Root received 915 restricted stock units (RSUs) of Common Stock on January 5, 2026. The award was granted at a price of $0 per share under Omada Health’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of Common Stock, with settlement to occur on a date Mr. Root selects under the program or as otherwise provided by the program. Following this grant, he beneficially owns 179,293 shares of Common Stock directly.

Insider Trade Summary

Grant/Award: 915 shares

Grant/Award 1 txn

Insider ROOT JONATHAN D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	915	$0.00	$0.00

Holdings After Transaction: Common Stock — 179,293 shares (Direct)

Holdings Before and After: Common Stock, 178,378 to 179,293 shares (Direct)

Footnotes (1)

F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report in this Form 4?

Omada Health reported that director Jonathan D. Root was granted 915 restricted stock units (RSUs) of Common Stock on January 5, 2026, at a price of $0 per share.

How many Omada Health (OMDA) shares does Jonathan D. Root own after this RSU grant?

After the reported RSU grant, Jonathan D. Root beneficially owns 179,293 shares of Omada Health Common Stock in direct ownership.

What do the 915 RSUs granted to Omada Health (OMDA) director Jonathan D. Root represent?

Each of the 915 RSUs represents the right to receive one share of Omada Health Common Stock, with settlement occurring on a date selected by Mr. Root under the Non-Employee Director Compensation Program or as otherwise provided by that program.

Why did Omada Health (OMDA) grant RSUs instead of cash to Jonathan D. Root?

The filing states the RSUs were granted in lieu of retainer fees under Omada Health’s Non-Employee Director Compensation Program, effectively replacing a portion of cash director compensation with equity-based awards.

Is the Omada Health (OMDA) RSU award to Jonathan D. Root a purchase or a grant?

The transaction is reported with code A and a price of $0 per share, indicating it is a grant of RSUs as part of Omada Health’s director compensation, not an open-market purchase.

Does Jonathan D. Root hold the Omada Health (OMDA) shares directly or indirectly?

The Form 4 reports direct ownership (D) for the 179,293 shares of Omada Health Common Stock beneficially owned following the RSU grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROOT JONATHAN D

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

94080

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/05/2026		A		915⁽¹⁾	A	$0	179,293	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR